Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	99.19	99.19	102.99	100.71	184.43	143.58
Short-Term Investments	578.28	578.28	292.74	268.39	183.36	171.91
Cash & Short-Term Investments	677.46	677.46	395.73	369.1	367.79	315.49
Cash Growth	71.19%	71.19%	7.21%	0.36%	16.58%	21.95%
Receivables	-	-	-	1.41	10.26	0.85
Prepaid Expenses	9.54	9.54	8.81	7.29	4.36	4.25
Restricted Cash	3.5	3.5	7.9	7.3	-	-
Other Current Assets	4.97	4.97	4.03	20.2	2.19	1.78
Total Current Assets	695.47	695.47	416.47	405.3	384.6	322.37
Property, Plant & Equipment	431.29	431.29	335.56	168.59	66.02	47.02
Long-Term Investments	-	-	-	105.87	245.6	137.49
Other Intangible Assets	8.56	8.56	10.26	11.96	13.66	15.36
Other Long-Term Assets	4.48	4.48	3.26	0.22	0.27	0.26
Total Assets	1,140	1,140	765.55	691.94	710.15	522.5
Accounts Payable	11.39	11.39	35.87	2.87	9.46	6.83
Accrued Expenses	80.8	80.8	43.68	59.11	23.77	13.45
Current Portion of Leases	6.34	6.34	10.56	2.78	2.25	1.1
Current Unearned Revenue	-	-	0.87	74.1	111.06	19.29
Other Current Liabilities	4.64	4.64	14.48	-	-	0.02
Total Current Liabilities	103.17	103.17	105.46	138.85	146.54	40.68
Long-Term Debt	734.54	734.54	268.33	-	-	-
Long-Term Leases	111.03	111.03	104.61	78.8	23.3	20.04
Long-Term Unearned Revenue	-	-	-	55.95	131.5	-
Total Liabilities	948.74	948.74	478.39	273.6	301.33	60.73
Common Stock	0.22	0.22	0.2	0.2	0.2	0.2
Additional Paid-In Capital	1,806	1,806	1,300	1,219	1,053	965.41
Retained Earnings	-1,626	-1,626	-1,026	-820.76	-644.69	-503.84
Comprehensive Income & Other	4.75	4.75	-3.22	-0.14	-0.07	0.02
Total Common Equity	185.44	185.44	271.34	398.52	408.82	461.78
Minority Interest	5.62	5.62	15.82	19.82	-	-
Shareholders' Equity	191.06	191.06	287.16	418.34	408.82	461.78
Total Liabilities & Equity	1,140	1,140	765.55	691.94	710.15	522.5
Total Debt	851.91	851.91	383.5	81.58	25.55	21.14
Net Cash (Debt)	-174.45	-174.45	12.23	287.52	342.24	294.36
Net Cash Growth	-	-	-95.75%	-15.99%	16.27%	13.78%
Net Cash Per Share	-1.46	-1.46	0.11	2.73	3.30	2.92
Filing Date Shares Outstanding	124.43	124.43	107.43	106.01	104.53	102.76
Total Common Shares Outstanding	124.38	124.38	107.31	105.96	104.33	102.38
Working Capital	592.3	592.3	311.02	266.45	238.06	281.69
Book Value Per Share	1.49	1.49	2.53	3.76	3.92	4.51
Tangible Book Value	176.88	176.88	261.08	386.56	395.16	446.42
Tangible Book Value Per Share	1.42	1.42	2.43	3.65	3.79	4.36
Land	3	3	3	3	-	-
Buildings	75.99	75.99	-	-	-	-
Machinery	71.93	71.93	58.75	40.47	29.67	21.32
Construction In Progress	188.73	188.73	166.66	56.37	0.35	-
Leasehold Improvements	104.41	104.41	103.81	42.02	41.52	25.24

Source: S&P Capital IQ. Standard template. Financial Sources.